Sequent Scientific Limited (SEQUENT.BO)
INR 136.85
(8.18%)
INR 136.85
(8.18%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 3.46 Billion INR | 0.04% |
| 2022 | 3.46 Billion INR | -0.54% |
| 2021 | 3.47 Billion INR | 31.63% |
| 2020 | 2.64 Billion INR | 20.48% |
| 2019 | 2.19 Billion INR | 9.65% |
| 2018 | 2 Billion INR | 26.19% |
| 2017 | 1.58 Billion INR | -1.39% |
| 2016 | 1.6 Billion INR | 19.05% |
| 2015 | 1.35 Billion INR | 43.15% |
| 2014 | 943.59 Million INR | -6.94% |
| 2013 | 1.01 Billion INR | 18.42% |
| 2012 | 856.21 Million INR | 25.47% |
| 2011 | 682.4 Million INR | 4.11% |
| 2010 | 655.47 Million INR | 16.4% |
| 2009 | 563.13 Million INR | 76.07% |
| 2008 | 319.84 Million INR | 100.51% |
| 2007 | 159.51 Million INR | 206.25% |
| 2006 | 52.08 Million INR | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 Q2 | 3.26 Billion INR | 0.0% |
| 2023 Q4 | 3.46 Billion INR | 0.0% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q3 | - INR | -100.0% |
| 2023 FY | 3.46 Billion INR | 0.04% |
| 2022 FY | 3.46 Billion INR | -0.54% |
| 2022 Q1 | - INR | -100.0% |
| 2022 Q2 | 3.71 Billion INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 Q4 | 3.46 Billion INR | 0.0% |
| 2021 Q2 | 3.27 Billion INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2021 FY | 3.47 Billion INR | 31.63% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q4 | 3.47 Billion INR | 0.0% |
| 2020 Q4 | 2.64 Billion INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 FY | 2.64 Billion INR | 20.48% |
| 2020 Q2 | 2.32 Billion INR | 0.0% |
| 2019 FY | 2.19 Billion INR | 9.65% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q4 | 2.19 Billion INR | 0.0% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q2 | 2.05 Billion INR | 0.0% |
| 2018 Q4 | 2 Billion INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 FY | 2 Billion INR | 26.19% |
| 2018 Q1 | - INR | -100.0% |
| 2018 Q2 | 1.94 Billion INR | 0.0% |
| 2017 Q2 | 1.94 Billion INR | 0.0% |
| 2017 FY | 1.58 Billion INR | -1.39% |
| 2017 Q4 | 1.58 Billion INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q1 | - INR | -100.0% |
| 2016 FY | 1.6 Billion INR | 19.05% |
| 2016 Q3 | - INR | -100.0% |
| 2016 Q2 | 1.74 Billion INR | 0.0% |
| 2016 Q1 | - INR | -100.0% |
| 2016 Q4 | 1.6 Billion INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2015 Q4 | 1.35 Billion INR | 0.0% |
| 2015 Q2 | 913.12 Million INR | 0.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 FY | 1.35 Billion INR | 43.15% |
| 2014 FY | 943.59 Million INR | -6.94% |
| 2014 Q2 | 814.82 Million INR | 0.0% |
| 2014 Q4 | 943.59 Million INR | 0.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q1 | - INR | -100.0% |
| 2013 FY | 1.01 Billion INR | 18.42% |
| 2013 Q4 | 1.01 Billion INR | 0.0% |
| 2012 Q2 | 1.23 Billion INR | 0.0% |
| 2012 Q4 | 856.21 Million INR | 0.0% |
| 2012 FY | 856.21 Million INR | 25.47% |
| 2011 FY | 682.4 Million INR | 4.11% |
| 2010 FY | 655.47 Million INR | 16.4% |
| 2009 FY | 563.13 Million INR | 76.07% |
| 2008 FY | 319.84 Million INR | 100.51% |
| 2007 FY | 159.51 Million INR | 206.25% |
| 2006 FY | 52.08 Million INR | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Alembic Pharmaceuticals Limited | 16.43 Billion INR | 78.934% |
| Aurobindo Pharma Limited | 98.08 Billion INR | 96.47% |
| Glenmark Life Sciences Limited | 6.66 Billion INR | 48.059% |
| Granules India Limited | 13 Billion INR | 73.378% |
| Indoco Remedies Limited | 3.53 Billion INR | 1.934% |
| Achyut Healthcare Limited | 568 Thousand INR | -609463.38% |
| Ajanta Pharma Limited | 8.28 Billion INR | 58.203% |
| Alkem Laboratories Limited | 26.61 Billion INR | 86.99% |
| Alpa Laboratories Limited | 136.65 Million INR | -2433.658% |
| Brooks Laboratories Limited | 96.1 Million INR | -3502.53% |
| AstraZeneca Pharma India Limited | 2.27 Billion INR | -51.935% |
| Bajaj HealthCare Limited | 1.44 Billion INR | -140.375% |
| Bliss GVS Pharma Limited | 1.18 Billion INR | -192.309% |
| Dr. Reddy's Laboratories Limited | 63.55 Billion INR | 94.552% |
| Eris Lifesciences Limited | 1.89 Billion INR | -83.161% |
| FDC Limited | 3.88 Billion INR | 10.969% |
| Glenmark Pharmaceuticals Limited | 25.13 Billion INR | 86.223% |
| Gufic Biosciences Limited | 2 Billion INR | -72.7% |
| Ind-Swift Laboratories Limited | 104.57 Million INR | -3210.785% |
| Ipca Laboratories Limited | 24.71 Billion INR | 85.99% |
| Jagsonpal Pharmaceuticals Limited | 149.97 Million INR | -2208.675% |
| Krebs Biochemicals & Industries Limited | 97.96 Million INR | -3434.278% |
| Lasa Supergenerics Limited | 190.43 Million INR | -1718.121% |
| Laurus Labs Limited | 18.45 Billion INR | 81.238% |
| Lupin Limited | 49.53 Billion INR | 93.011% |
| Mankind Pharma Limited | 15.53 Billion INR | 77.712% |
| Medicamen Biotech Limited | 593.75 Million INR | -483.126% |
| Medico Remedies Limited | 163.37 Million INR | -2019.286% |
| Megasoft Limited | - INR | -Infinity% |
| NATCO Pharma Limited | 7 Billion INR | 50.574% |
| Piramal Pharma Limited | 21.75 Billion INR | 84.088% |
| RPG Life Sciences Limited | 1.01 Billion INR | -242.804% |
| Sigachi Industries Limited | 707.2 Million INR | -389.577% |
| Sun Pharmaceutical Industries Limited | 98.68 Billion INR | 96.491% |
| Suven Pharmaceuticals Limited | 2.31 Billion INR | -49.757% |
| Syncom Formulations (India) Limited | 210.81 Million INR | -1542.35% |
| Unichem Laboratories Limited | 7.04 Billion INR | 50.867% |
| Wanbury Limited | 360.23 Million INR | -861.136% |
| Windlas Biotech Limited | 621.89 Million INR | -456.742% |
| ZIM Laboratories Limited | 812.62 Million INR | -326.064% |
| Zydus Lifesciences Limited | 34.41 Billion INR | 89.941% |
| Sun Pharma Advanced Research Company Limited | - INR | -Infinity% |
| Divi's Laboratories Limited | 31.84 Billion INR | 89.126% |
| Hester Biosciences Limited | 755.81 Million INR | -358.094% |
| Procter & Gamble Health Limited | 1.09 Billion INR | -217.324% |
| Amrutanjan Health Care Limited | 289.04 Million INR | -1097.84% |
| Bal Pharma Limited | 878.11 Million INR | -294.29% |
| Strides Pharma Science Limited | 11.26 Billion INR | 69.258% |
| Venus Remedies Limited | 1.21 Billion INR | -184.52% |
| Aarti Pharmalabs Limited | 6.42 Billion INR | 46.142% |
| Nectar Lifesciences Limited | 7.09 Billion INR | 51.177% |
| Shilpa Medicare Limited | 3.44 Billion INR | -0.378% |
| Aarti Drugs Limited | 4.85 Billion INR | 28.743% |
| IOL Chemicals and Pharmaceuticals Limited | 4.24 Billion INR | 18.503% |
| Suven Life Sciences Limited | 7.08 Million INR | -48768.313% |
| Ind-Swift Limited | 640.91 Million INR | -440.215% |
| Valiant Laboratories Limited | 100.15 Million INR | -3356.996% |
| J. B. Chemicals & Pharmaceuticals Limited | 5.02 Billion INR | 31.099% |
| Solara Active Pharma Sciences Limited | 3.59 Billion INR | 3.744% |
| Themis Medicare Limited | 705.74 Million INR | -390.592% |
| Hikal Limited | 3.03 Billion INR | -13.997% |
| Torrent Pharmaceuticals Limited | 22.79 Billion INR | 84.808% |
| Novartis India Limited | 448.6 Million INR | -671.806% |
| Wockhardt Limited | 6.4 Billion INR | 45.901% |
| Jubilant Pharmova Limited | 12.89 Billion INR | 73.152% |
| Biofil Chemicals and Pharmaceuticals Limited | 25.49 Million INR | -13479.323% |
| Neuland Laboratories Limited | 3.5 Billion INR | 1.196% |
| Morepen Laboratories Limited | 2.48 Billion INR | -39.276% |
| Kilitch Drugs (India) Limited | 39.88 Million INR | -8581.846% |
| Mangalam Drugs & Organics Limited | 1.23 Billion INR | -180.033% |